About This clinical research study
The research team at MAC Clinical Research are conducting a study to test an existing medication to see if the treatment may help with cognition in people living with memory problems and Mild Cognitive Impairment (MCI) (for example, whether the medicine may improve remembering, thinking, attention and problem-solving).
What is MCI? Mild Cognitive Impairment (MCI) is a condition that causes minor problems with cognition – mental abilities such as memory or thinking. MCI causes cognitive changes that are serious enough to be noticed to the person affected and to family members and friends, but do not affect the individual’s ability to carry out everyday activities. Approximately 15% to 20% of people age 65 or older have MCI.
Medication repositioning (or repurposing) identifies new disease areas for an existing treatment that is already on the market.
Medication ‘repositioning’ has many advantages over traditional medicine discovery approaches. It can significantly reduce development time, and as compounds have demonstrated safety in people, it often avoids the need for large, expensive trials that can take many years to complete.
£1,380 plus travel or transport
Clinics
Greater Manchester
Therapy Area
Mild Cognitive Impairment
Gender and Age
Males and Females aged 40 - 75
A full description of the study would be given to you before you decide to take part, both over the phone and during an appointment at the MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.
If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.
The study will run at our clinic in Manchester and will require 4 outpatient visits and 2 single night residential visits (overnight) over 9 weeks.
All eligible participants will receive the study medication during one of the two, 7-day treatment periods during the trial.
Reimbursement: £1,380 plus travel or transport
Key Inclusion Criteria
- Age 40-75
- Diagnosis of MCI or a history of gradual subjective memory decline over the last year
Key Exclusion Criteria
- Unable to attend study visits or comply with study restrictions
Other eligibility criteria will apply. Please contact MAC for more information.
Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.
ABOUT CLINICAL RESEARCH STUDIES
Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.
If the study is successful, it may be an important step towards developing a promising new treatment.
If you would like more information, please fill in the form below and we will be in touch…
Alternatively, please call our recruitment team on freephone 0800 633 5507.
Know someone who may be interested in taking part? Share this page here:
